A
Aura Biosciences, Inc. (AURA)
NGM – Real vaqt narxi. Valyuta: USD
7.93
-0.26 (-3.17%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
7.93
-0.26 (-3.17%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aura Biosciences, Inc., klinik rivojlanish bosqichidagi biotexnologiya kompaniyasi, qattiq o'smalarni davolash uchun aniq terapiyalarni ishlab chiqadi. Kompaniyaning o'ziga xos platformasi virusga o'xshash dori kon'yugatlarini yaratish uchun dorilar bilan kon'yugatsiya qilingan yoki nuklein kislotalar bilan yuklangan virusga o'xshash zarralar yordamida turli xil qattiq o'smalarni nishonga olish imkonini beradi. Uning asosiy nomzodi bel-sar bo'lib, u birlamchi xorioidal melanomali va boshqa ko'z onkologiyasi ko'rsatmalari bo'lgan bemorlarni davolash uchun kechki bosqichdagi klinik rivojlanishda, shuningdek, siydik pufagi saratoni uchun erta bosqichdagi klinik rivojlanishda. Kompaniya siydik pufagi saratoni, shu jumladan, turli xil qattiq o'smalarni davolashda bel-sarning xavfsizligi va samaradorligini baholashga qaratilgan. Kompaniya 2009 yilda tashkil etilgan va shtab-kvartirasi Massachusets shtatining Boston shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Anthony Daniels M.D. | VP & Therapeutic Area of Head Ocular Oncology |
| Dr. Jill J. Hopkins M.D. | Chief Medical Officer & President of Research and Development |
| Dr. Mark Plavsic D.V.M., Ph.D. | Chief Technology Officer |
| Dr. Sabine Brookman-May M.D. | Senior VP & Therapeutic Area Head of Urologic Oncology |
| Mr. Anthony S. Gibney | Chief Financial & Business Officer |
| Mr. Conor Kilroy | Chief Legal Officer & Secretary |
| Mr. Patrick Nealon | Senior Vice President of Clinical Development Operations |
| Ms. Amy Elazzouzi | Interim Principal Accounting Officer, Senior VP of Finance & Treasurer |
| Ms. Natalie C. Holles | President, CEO & Director |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-05 | 8-K | d133115d8k.htm |
| 2026-05-04 | DEFA14A | d117008ddefa14a.htm |
| 2026-04-20 | DEFA14A | defa_2026.htm |
| 2026-03-30 | 8-K | aura-20260330.htm |
| 2025-11-13 | 8-K | aura-20251113.htm |
| 2025-11-13 | 10-Q | aura-20250930.htm |
| 2025-08-13 | 8-K | aura-20250813.htm |
| 2025-06-18 | 8-K | aura-20250617.htm |
| 2025-05-16 | 8-K | d213451d8k.htm |
| 2025-05-15 | 8-K | aura-20250513.htm |